197 related articles for article (PubMed ID: 36995085)
1. Unraveling the genetics of transformed splenic marginal zone lymphoma.
Grau M; López C; Navarro A; Frigola G; Nadeu F; Clot G; Bastidas-Mora G; Alcoceba M; Baptista MJ; Blanes M; Colomer D; Costa D; Domingo-Domènech E; Enjuanes A; Escoda L; Forcada P; Giné E; Lopez-Guerra M; Ramón O; Rivas-Delgado A; Vicente Folch L; Wotherspoon A; Climent F; Campo E; López-Guillermo A; Matutes E; Beà S
Blood Adv; 2023 Jul; 7(14):3695-3709. PubMed ID: 36995085
[TBL] [Abstract][Full Text] [Related]
2. Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis.
Watkins AJ; Huang Y; Ye H; Chanudet E; Johnson N; Hamoudi R; Liu H; Dong G; Attygalle A; McPhail ED; Law ME; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
J Pathol; 2010 Mar; 220(4):461-74. PubMed ID: 20077527
[TBL] [Abstract][Full Text] [Related]
3. Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases.
Camacho FI; Mollejo M; Mateo MS; Algara P; Navas C; Hernández JM; Santoja C; Solé F; Sánchez-Beato M; Piris MA
Am J Surg Pathol; 2001 Oct; 25(10):1268-76. PubMed ID: 11688461
[TBL] [Abstract][Full Text] [Related]
4. KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype.
Clipson A; Wang M; de Leval L; Ashton-Key M; Wotherspoon A; Vassiliou G; Bolli N; Grove C; Moody S; Escudero-Ibarz L; Gundem G; Brugger K; Xue X; Mi E; Bench A; Scott M; Liu H; Follows G; Robles EF; Martinez-Climent JA; Oscier D; Watkins AJ; Du MQ
Leukemia; 2015 May; 29(5):1177-85. PubMed ID: 25428260
[TBL] [Abstract][Full Text] [Related]
5. Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation.
Bastidas-Mora G; Beà S; Navarro A; Gine E; Costa D; Delgado J; Baumann T; Magnano L; Rivas-Delgado A; Villamor N; Colomer D; Lopez-Guerra M; Rozman M; Balagué O; Martínez D; Baptista MJ; Escoda L; Alcoceba M; Blanes M; Climent F; Campo E; Wotherspoon A; López-Guillermo A; Matutes E
Br J Haematol; 2022 Jan; 196(1):146-155. PubMed ID: 34519021
[TBL] [Abstract][Full Text] [Related]
6. Splenic small B-cell lymphoma with predominant red pulp involvement: a diffuse variant of splenic marginal zone lymphoma?
Mollejo M; Algara P; Mateo MS; Sánchez-Beato M; Lloret E; Medina MT; Piris MA
Histopathology; 2002 Jan; 40(1):22-30. PubMed ID: 11903595
[TBL] [Abstract][Full Text] [Related]
7. Exome sequencing identifies recurrent
Jallades L; Baseggio L; Sujobert P; Huet S; Chabane K; Callet-Bauchu E; Verney A; Hayette S; Desvignes JP; Salgado D; Levy N; Béroud C; Felman P; Berger F; Magaud JP; Genestier L; Salles G; Traverse-Glehen A
Haematologica; 2017 Oct; 102(10):1758-1766. PubMed ID: 28751561
[TBL] [Abstract][Full Text] [Related]
8. 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma.
Mateo M; Mollejo M; Villuendas R; Algara P; Sanchez-Beato M; Martínez P; Piris MA
Am J Pathol; 1999 May; 154(5):1583-9. PubMed ID: 10329610
[TBL] [Abstract][Full Text] [Related]
9. Novel genomic imbalances in B-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogenetics.
Hernández JM; García JL; Gutiérrez NC; Mollejo M; Martínez-Climent JA; Flores T; González MB; Piris MA; San Miguel JF
Am J Pathol; 2001 May; 158(5):1843-50. PubMed ID: 11337382
[TBL] [Abstract][Full Text] [Related]
10. Myeloid nuclear differentiation antigen: an aid in differentiating lymphoplasmacytic lymphoma and splenic marginal zone lymphoma in bone marrow biopsies at presentation.
Righi S; Novero D; Godio L; Bertuzzi C; Bacci F; Agostinelli C; Sagramoso C; Rossi M; Piccioli M; Gazzola A; Mannu C; Roncador G; Sabattini E
Hum Pathol; 2022 Jun; 124():67-75. PubMed ID: 35339566
[TBL] [Abstract][Full Text] [Related]
11. A narrow deletion of 7q is common to HCL, and SMZL, but not CLL.
Andersen CL; Gruszka-Westwood A; Østergaard M; Koch J; Jacobsen E; Kjeldsen E; Nielsen B
Eur J Haematol; 2004 Jun; 72(6):390-402. PubMed ID: 15128417
[TBL] [Abstract][Full Text] [Related]
12. Genomic abnormalities acquired in the blastic transformation of splenic marginal zone B-cell lymphoma.
Martinez-Climent JA; Sanchez-Izquierdo D; Sarsotti E; Blesa D; Benet I; Climent J; Vizcarra E; Marugan I; Terol MJ; Sole F; Cigudosad JC; Siebert R; Dyer MJ; García-Conde J
Leuk Lymphoma; 2003 Mar; 44(3):459-64. PubMed ID: 12688315
[TBL] [Abstract][Full Text] [Related]
13. High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma.
Fresquet V; Robles EF; Parker A; Martinez-Useros J; Mena M; Malumbres R; Agirre X; Catarino S; Arteta D; Osaba L; Mollejo M; Hernandez-Rivas JM; Calasanz MJ; Daibata M; Dyer MJ; Prosper F; Vizcarra E; Piris MÁ; Oscier D; Martinez-Climent JA
Br J Haematol; 2012 Sep; 158(6):712-26. PubMed ID: 22816737
[TBL] [Abstract][Full Text] [Related]
14. Aggressive variant of splenic marginal zone lymphoma characterized using a cancer panel test and treated with rituximab-containing chemotherapy: A case report.
Ishiguro K; Sasaki Y; Takagi Y; Niinuma T; Suzuki H; Tokino T; Hayashi T; Takahashi T; Igarashi T; Matsuno Y
Medicine (Baltimore); 2020 Aug; 99(35):e21938. PubMed ID: 32871937
[TBL] [Abstract][Full Text] [Related]
15. Molecular heterogeneity of splenic marginal zone lymphomas: analysis of mutations in the 5' non-coding region of the bcl-6 gene.
Mateo MS; Mollejo M; Villuendas R; Algara P; Sanchez-Beato M; Martínez P; Piris MA
Leukemia; 2001 Apr; 15(4):628-34. PubMed ID: 11368366
[TBL] [Abstract][Full Text] [Related]
16. Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma.
Kiel MJ; Velusamy T; Betz BL; Zhao L; Weigelin HG; Chiang MY; Huebner-Chan DR; Bailey NG; Yang DT; Bhagat G; Miranda RN; Bahler DW; Medeiros LJ; Lim MS; Elenitoba-Johnson KS
J Exp Med; 2012 Aug; 209(9):1553-65. PubMed ID: 22891276
[TBL] [Abstract][Full Text] [Related]
17. Genetic and phenotypic attributes of splenic marginal zone lymphoma.
Bonfiglio F; Bruscaggin A; Guidetti F; Terzi di Bergamo L; Faderl M; Spina V; Condoluci A; Bonomini L; Forestieri G; Koch R; Piffaretti D; Pini K; Pirosa MC; Cittone MG; Arribas A; Lucioni M; Ghilardi G; Wu W; Arcaini L; Baptista MJ; Bastidas G; Bea S; Boldorini R; Broccoli A; Buehler MM; Canzonieri V; Cascione L; Ceriani L; Cogliatti S; Corradini P; Derenzini E; Devizzi L; Dietrich S; Elia AR; Facchetti F; Gaidano G; Garcia JF; Gerber B; Ghia P; Gomes da Silva M; Gritti G; Guidetti A; Hitz F; Inghirami G; Ladetto M; Lopez-Guillermo A; Lucchini E; Maiorana A; Marasca R; Matutes E; Meignin V; Merli M; Moccia A; Mollejo M; Montalban C; Novak U; Oscier DG; Passamonti F; Piazza F; Pizzolitto S; Rambaldi A; Sabattini E; Salles G; Santambrogio E; Scarfò L; Stathis A; Stüssi G; Geyer JT; Tapia G; Tarella C; Thieblemont C; Tousseyn T; Tucci A; Vanini G; Visco C; Vitolo U; Walewska R; Zaja F; Zenz T; Zinzani PL; Khiabanian H; Calcinotto A; Bertoni F; Bhagat G; Campo E; De Leval L; Dirnhofer S; Pileri SA; Piris MA; Traverse-Glehen A; Tzankov A; Paulli M; Ponzoni M; Mazzucchelli L; Cavalli F; Zucca E; Rossi D
Blood; 2022 Feb; 139(5):732-747. PubMed ID: 34653238
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.
Salido M; Baró C; Oscier D; Stamatopoulos K; Dierlamm J; Matutes E; Traverse-Glehen A; Berger F; Felman P; Thieblemont C; Gesk S; Athanasiadou A; Davis Z; Gardiner A; Milla F; Ferrer A; Mollejo M; Calasanz MJ; Florensa L; Espinet B; Luño E; Wlodarska I; Verhoef G; García-Granero M; Salar A; Papadaki T; Serrano S; Piris MA; Solé F
Blood; 2010 Sep; 116(9):1479-88. PubMed ID: 20479288
[TBL] [Abstract][Full Text] [Related]
19. The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development.
Rossi D; Trifonov V; Fangazio M; Bruscaggin A; Rasi S; Spina V; Monti S; Vaisitti T; Arruga F; Famà R; Ciardullo C; Greco M; Cresta S; Piranda D; Holmes A; Fabbri G; Messina M; Rinaldi A; Wang J; Agostinelli C; Piccaluga PP; Lucioni M; Tabbò F; Serra R; Franceschetti S; Deambrogi C; Daniele G; Gattei V; Marasca R; Facchetti F; Arcaini L; Inghirami G; Bertoni F; Pileri SA; Deaglio S; Foà R; Dalla-Favera R; Pasqualucci L; Rabadan R; Gaidano G
J Exp Med; 2012 Aug; 209(9):1537-51. PubMed ID: 22891273
[TBL] [Abstract][Full Text] [Related]
20. Characterization of immune exhaustion and suppression in the tumor microenvironment of splenic marginal zone lymphoma.
Anagnostou T; Yang ZZ; Jalali S; Kim HJ; Larson DP; Tang X; Yu Y; Pritchett JC; Bisneto JV; Price-Troska TL; Mondello P; Novak AJ; Ansell SM
Leukemia; 2023 Jul; 37(7):1485-1498. PubMed ID: 37117318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
